Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PACS · against 588 other Healthcare companies listed in US-listed
Ranked #139 of 589 · scores higher than 76% of peers
Bars: peers in each 10-point band of the valuation score57 peers with a valuation score of 50–59, including PACS · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | PACS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 3.7% | -4.3% | 82% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 4.5% | -0.8% | 68% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 1.6% | -2.3% | 65% | 20% | |
| Book yieldHigher is better · 587 reported | 15.0% | 25.9% | 33% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 132 | 119.1B USD | 59 | 57 | |
| 132 | 5.3B USD | 59 | 63 | |
| 139 | 58.6B USD | 58 | 52 | |
| 139 | 641.4B USD | 58 | 59 | |
| 139 | 7.4B USD | 58 | 67 | |
| 139 | 12.6B USD | 58 | 55 | |
| 139 | 2.2B USD | 58 | 61 | |
| 144 | 189.3B USD | 57 | 45 | |
| 144 | 2.8B USD | 57 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score